Calicheamicin Synthesis Using Bifunctional Linker Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic methods for constructing calicheamicin derivatives are complicated and have low overall yields, posing safety concerns due to the inherent toxicity of the calicheamicin moiety.
Innovation Solution
A process involving bifunctional and trifunctional linker intermediates is developed, which includes reacting a carboxylic acid with a mercapto compound, followed by activation with N-hydroxysuccinimide and subsequent reaction with a methyltrithio antitumor antibiotic, to produce calicheamicin derivatives with increased yields and reduced toxicity exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional synthetic methods are used to construct calicheamicin derivatives, then the synthesis can be completed, but the overall yield is low and the process is complicated
Solution Approach 1:
The synthesis is divided into modular segments: a calicheamicin gamma-lactone core module, a linker module (bifunctional or trifunctional), and a biomacromolecule module. This segmentation allows independent optimization of each module and simplifies the overall synthetic process while improving overall yield.
Solution Approach 2:
The calicheamicin gamma-lactone core and linkers are prepared in advance through convergent synthesis pathways. The core is pre-functionalized with protecting groups and the linkers are pre-synthesized with appropriate reactive groups, allowing these modules to be stored and then rapidly assembled with the biomacromolecule target.
2Ease of operation
If traditional synthetic methods with multiple calicheamicin-containing steps are used, then the synthesis can proceed, but safety precautions must be increased due to inherent toxicity
Solution Approach 1:
The toxic calicheamicin gamma-lactone core is extracted and isolated as a separate, stable module. This allows the core to be handled in controlled conditions during its preparation, and then the less toxic linker and biomacromolecule components can be assembled separately before final coupling, minimizing overall toxicity exposure during the synthetic process.
Solution Approach 2:
Stable linker intermediates (bifunctional or trifunctional linkers with protecting groups) serve as mediators between the toxic calicheamicin core and the biomacromolecule target. These linkers allow the toxic core to be kept separate from the biological component until the final assembly step, reducing toxicity exposure during intermediate handling and purification steps.
3Productivity
If convergent synthesis with bifunctional and trifunctional linkers is used, then the synthesis is simplified with higher yields, but the process requires precise control of reaction conditions
Solution Approach 1:
Different regions of the molecule are prepared with locally optimized properties: the calicheamicin core has specific protecting groups (acetates, benzoyls) tailored to its reactivity, the linkers have functional groups (carboxylic acids, hydroxyls, amines) positioned to enable selective coupling, and the biomacromolecule has accessible nucleophilic sites. This local quality optimization allows each module to react selectively under mild, well-controlled conditions.
Solution Approach 2:
The synthesis utilizes controlled changes in reaction parameters (pH, temperature, solvent composition, stoichiometry) to drive each coupling step. For example, carbodiimide-mediated couplings are performed at controlled pH to activate carboxylic acids, and the stoichiometry of reactants is precisely controlled to ensure complete reaction while minimizing side products.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process simplifies the synthesis of calicheamicin derivatives with higher yields and improved safety by minimizing the handling of the toxic calicheamicin moiety, while maintaining the antibacterial and antitumor properties.
Implementation Method 1
reacting a carboxylic acid with a mercapto compound to produce a bilinker-carboxylic acid
Implementation Method 2
activation with N-hydroxysuccinimide
Implementation Method 3
subsequent reaction with a methyltrithio antitumor antibiotic, to produce calicheamicin derivatives
Data Source
AI summary
This invention describes processes for the convergent synthesis of calicheamicin derivatives, and similar analogs using bifunctional and trifunctional linker intermediates.